Past Meeting | Keystone Symposia

This meeting took place in the past. Here is a list of meetings that are related:
Prevention of HIV/AIDS (2009X3)
HIV Vaccines: Progress and Prospects (2008X7)
HIV Vaccines: From Basic Research to Clinical Trials (2007X7)
HIV Vaccines (2006X6)
HIV Vaccines: Current Challenges and Future Prospects (2005X8)
HIV Vaccine Development: Progress and Prospects (2004X8)

Web Desc
HIV Vaccine Development: Immunological and Biological Challenges joint with Twenty Years of HIV Research: From Discovery to Understanding Organizer(s): Richard A. Koup, David C. Montefiori and Brigitte Autran Date: March 29 - April 04, 2003 Location: Fairmont Banff Springs, Banff, AB, Canada Sponsored by Wyeth Vaccines Research Summary of Meeting: Our efforts to curtail the worldwide spread of HIV infection are bolstered by the fact that we now have new information on the molecular and immunological basis of HIV infection. An intimate understanding of immunological control of HIV, and mechanisms by which HIV escapes that control, form the basis of developing novel strategies to prevent infection and disease. Many new vaccine products are now being tested in animal and human trials. Unlike other infections that have been prevented by vaccination, HIV specifically infects and destroys a key component of the immune response to intracellular pathogens. In addition, HIV is exquisitely capable of evading neutralizing antibody responses. All attempts to eliminate HIV from infected individuals have failed. The overall goal of this symposium will be to integrate the newest information on the molecular and cellular biology of HIV infection, the immune response to that infection, and the results of clinical trials of vaccine products. The program will identify the advances that have been made, and the challenges that remain, in developing a vaccine against HIV. The interaction between basic and applied scientists will foster accelerated research and development on HIV vaccines. Discounted Abstract Deadline: December 31 2002 Discounted Registration Deadline: January 29 2003 We gratefully acknowledge additional support for this conference from: We gratefully acknowledge the generous grant for this conference provided by: National Institute of Allergy and Infectious Diseases (NIAID) Grant No. 1 R13 AI053895-01 We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising: Click here to view more of these organizations Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds: Click here to view more of these organizations

Web Desc

HIV Vaccine Development: Immunological and Biological Challenges

joint with Twenty Years of HIV Research: From Discovery to Understanding

Organizer(s): Richard A. Koup, David C. Montefiori and Brigitte Autran

Date: March 29 - April 04, 2003
Location: Fairmont Banff Springs, Banff, AB, Canada

Program


Saturday, March 29 \| 3:00PM - 7:00PM Registration Room: Van Horne Foyer
Saturday, March 29 \| 6:15PM - 7:15PM Welcome Room: Van Horne Foyer
Saturday, March 29 \| 7:15PM - 7:30PM Orientation Room: Van Horne Ballroom
Saturday, March 29 \| 7:30PM - 9:30PM Keynote Addresses (Joint) Room: Van Horne Ballroom Speaker 1 of 4 * Jay A. Levy, University of California, San Francisco, USA
Saturday, March 29 \| 7:30PM - 9:30PM Keynote Addresses (Joint) Room: Van Horne Ballroom Speaker 2 of 4 * Richard A. Koup, NIAID, National Institutes of Health, USA
Saturday, March 29 \| 7:30PM - 9:30PM Keynote Addresses (Joint) Room: Van Horne Ballroom Speaker 3 of 4 Daniel Tarantola, University of New South Wales, Australia HIV/AIDS: Status of the Worldwide Epidemic
Saturday, March 29 \| 7:30PM - 9:30PM Keynote Addresses (Joint) Room: Van Horne Ballroom Speaker 4 of 4 Richard B. Gaynor, Neon Therapeutics, USA Intracellular Events Involved in HIV-1 Replication
Sunday, March 30 \| 6:30AM - 8:00AM Breakfast Room: New Brunswick (NB)/Riverview/Cascade/Conservatory
Sunday, March 30 \| 8:00AM - 11:00AM Pioneer Lecture - Virology (Joint) Room: Van Horne Ballroom Speaker 1 of 1 * Mario Stevenson, University of Miami, Leonard M. Miller School of Medicine, USA
Sunday, March 30 \| 8:00AM - 11:00AM Viral Diversity I (Joint) Room: Van Horne Ballroom Speaker 1 of 4 Robert W. Doms, University of Pennsylvania School of Medicine, USA Virus Interaction at the Cell Surface
Sunday, March 30 \| 8:00AM - 11:00AM Viral Diversity I (Joint) Room: Van Horne Ballroom Speaker 2 of 4 James E.K. Hildreth, UC Davis College of Biological Sciences, USA HIV-1, Lipid Rafts, and Primary Macrophages: Modeling HIV-1 as a Trojan Exosome
Sunday, March 30 \| 8:00AM - 11:00AM Viral Diversity I (Joint) Room: Van Horne Ballroom Speaker 3 of 4 * David I. Watkins, University of Miami, USA SIV Diversity and Cellular Immune Responses
Sunday, March 30 \| 8:00AM - 11:00AM Viral Diversity I (Joint) Room: Van Horne Ballroom Speaker 4 of 4 Cecilia Cheng-Mayer, Aaron Diamond AIDS Research Center (ADARC), USA Impact of HIV-1 Coreceptor Usage/Tropism on Viral Transmission, Persistence and Pathogenesis
Sunday, March 30 \| 9:20AM - 9:40AM Coffee Break Room: Van Horne Foyer
Sunday, March 30 \| 11:00AM - 1:00PM Poster Setup Room: Alberta/NB/Riverview/Cascade/Conservatory
Sunday, March 30 \| 1:00PM - 10:00PM Poster Viewing Room: Alberta/NB/Riverview/Cascade/Conservatory
Sunday, March 30 \| 4:30PM - 5:00PM Coffee & Snacks Available Room: Van Horne Foyer
Sunday, March 30 \| 5:00PM - 7:00PM Viral Diversity II (Joint) Room: Van Horne Ballroom Speaker 1 of 6 * Preston A. Marx, Tulane National Primate Research Center, USA
Sunday, March 30 \| 5:00PM - 7:00PM Viral Diversity II (Joint) Room: Van Horne Ballroom Speaker 2 of 6 * Robert W. Coombs, University of Washington, USA
Sunday, March 30 \| 5:00PM - 7:00PM Viral Diversity II (Joint) Room: Van Horne Ballroom Speaker 3 of 6 Bette Tina Marie Korber, Los Alamos National Laboratory, USA Recombination: Now You See It, Now You Don't
Sunday, March 30 \| 5:00PM - 7:00PM Viral Diversity II (Joint) Room: Van Horne Ballroom Speaker 4 of 6 Julie M. Overbaugh, Fred Hutchinson Cancer Research Center, USA The Role of Hormones and Viral Diversity in HIV-1 Pathogenesis.
Sunday, March 30 \| 5:00PM - 7:00PM Viral Diversity II (Joint) Room: Van Horne Ballroom Speaker 5 of 6 Phyllis J. Kanki, Harvard School of Public Health, USA Pathogenesis of HIV Infections of Africa
Sunday, March 30 \| 5:00PM - 7:00PM Viral Diversity II (Joint) Room: Van Horne Ballroom Speaker 6 of 6 Vanessa M. Hirsch, NIAID, National Institutes of Health, USA Diversity of SIV: Relationship to Pathogenesis and Vaccine Development
Sunday, March 30 \| 7:30PM - 8:30PM Social Hour Room: Alberta/NB/Riverview/Cascade/Conservatory
Sunday, March 30 \| 8:00PM - 10:00PM Poster Session 1: CD8 T Cell Immune Responses Room: Alberta/NB/Riverview/Cascade/Conservatory
Monday, March 31 \| 6:30AM - 8:00AM Breakfast Room: New Brunswick/Riverview/Cascade/Conservatory
Monday, March 31 \| 8:00AM - 11:00AM Pioneer Lecture - Epidemiology This session is from HIV Research Room: Van Horne Ballroom C Speaker 1 of 3 * Jan Andersson, Karolinska Institutet, Sweden
Monday, March 31 \| 8:00AM - 11:00AM Pioneer Lecture - Epidemiology This session is from HIV Research Room: Van Horne Ballroom C Speaker 2 of 3 * Richard W. Price, University of California, San Francisco, USA
Monday, March 31 \| 8:00AM - 11:00AM Pioneer Lecture - Epidemiology This session is from HIV Research Room: Van Horne Ballroom C Speaker 3 of 3 Harold W. Jaffe, Centers for Disease Control and Prevention, USA HIV Epidemiology: Then and Now
Monday, March 31 \| 8:00AM - 11:00AM New Findings From Human Clinical Trials Room: Van Horne Ballroom A-B Speaker 1 of 5 Emilio A. Emini, Bill and Melinda Gates Foundation, USA Ongoing Development and Evaluation of a Potential HIV-1 Vaccine Using a Replication-Defective Adenoviral Vector
Monday, March 31 \| 8:00AM - 11:00AM New Findings From Human Clinical Trials Room: Van Horne Ballroom A-B Speaker 2 of 5 * Andrew J. McMichael, Oxford University, UK On the AIDS Vaccine Trail
Monday, March 31 \| 8:00AM - 11:00AM New Findings From Human Clinical Trials Room: Van Horne Ballroom A-B Speaker 3 of 5 Barney S. Graham, NIAID, National Institutes of Health, USA Update on Vaccine Research Center Clinical Trials of Candidate HIV Vaccines
Monday, March 31 \| 8:00AM - 11:00AM New Findings From Human Clinical Trials Room: Van Horne Ballroom A-B Speaker 4 of 5 M. Juliana McElrath, Fred Hutchinson Cancer Research Center, USA Induction of Vaccine-Induced T Cell Responses and Their Role in HIV-1 Protection
Monday, March 31 \| 8:00AM - 11:00AM New Findings From Human Clinical Trials Room: Van Horne Ballroom A-B Speaker 5 of 5 Phillip W. Berman, University of California, Santa Cruz, USA Preliminary Results of the Phase III Efficacy Trial of AIDSVAX B/B
Monday, March 31 \| 8:00AM - 11:00AM HIV Pathogenesis I This session is from HIV Research Room: Van Horne Ballroom C Speaker 1 of 4 Gene M. Shearer, National Cancer Institute, National Institutes of Health, USA HIV-1 Pathogenesis: Revisiting Discarded and Ignored Models
Monday, March 31 \| 8:00AM - 11:00AM HIV Pathogenesis I This session is from HIV Research Room: Van Horne Ballroom C Speaker 2 of 4 Clayton A. Wiley, University of Pittsburgh, USA HIV and the Brain: What Have We Learned and Where Are We Going?
Monday, March 31 \| 8:00AM - 11:00AM HIV Pathogenesis I This session is from HIV Research Room: Van Horne Ballroom C Speaker 3 of 4 Donald P. Kotler, St. Luke's Roosevelt Hospital Center, USA HIV Pathogenesis in the Gastrointestinal Tract
Monday, March 31 \| 8:00AM - 11:00AM HIV Pathogenesis I This session is from HIV Research Room: Van Horne Ballroom C Speaker 4 of 4 Paul Klotman, Mount Sinai Medical Center, USA Renal Epithelium is a Reservoir for HIV-1 Replication
Monday, March 31 \| 9:20AM - 9:40AM Coffee Break Room: Van Horne Foyer
Monday, March 31 \| 11:00AM - 1:00PM Poster Setup Room: Alberta/NB/Riverview/Cascade/Conservatory
Monday, March 31 \| 1:00PM - 10:00PM Poster Viewing Room: Alberta/NB/Riverview/Cascade/Conservatory
Monday, March 31 \| 4:30PM - 5:00PM Coffee & Snacks Available Room: Van Horne Foyer
Monday, March 31 \| 5:00PM - 7:00PM Pre-Clinical Leads in Non-Human Primates Room: Van Horne Ballroom A-B Speaker 1 of 4 Norman L. Letvin, Beth Israel Deaconess Medical Center, USA Defining Protective Immunity to SHIV in Non-Human Primates
Monday, March 31 \| 5:00PM - 7:00PM Pre-Clinical Leads in Non-Human Primates Room: Van Horne Ballroom A-B Speaker 2 of 4 Ronald C. Desrosiers, University of Miami Miller School of Medicine, USA Single Cycle SIV as a Vaccine Approach for AIDS Factors that Influence Resistance to Antibody-Mediated Neutralization
Monday, March 31 \| 5:00PM - 7:00PM Pre-Clinical Leads in Non-Human Primates Room: Van Horne Ballroom A-B Speaker 3 of 4 * Harriet L. Robinson, GeoVax Inc., USA A Multiprotein DNA/MVA Vaccine for AIDS
Monday, March 31 \| 5:00PM - 7:00PM Pre-Clinical Leads in Non-Human Primates Room: Van Horne Ballroom A-B Speaker 4 of 4 John K. Rose, Yale University School of Medicine, USA A Single VSV/SHIV Immunization Followed by One Heterologous MVA/SHIV Boost Results in Effective Control of Peak Virus Load After SHIV Challenge
Monday, March 31 \| 5:00PM - 7:00PM HIV Pathogenesis II This session is from HIV Research Room: Van Horne Ballroom C Speaker 1 of 6 * Anthony L. Cunningham, Westmead Institute for Medical Research, Australia
Monday, March 31 \| 5:00PM - 7:00PM HIV Pathogenesis II This session is from HIV Research Room: Van Horne Ballroom C Speaker 2 of 6 * Susan F. Plaeger, NIAID, National Institutes of Health, HHS, USA
Monday, March 31 \| 5:00PM - 7:00PM HIV Pathogenesis II This session is from HIV Research Room: Van Horne Ballroom C Speaker 3 of 6 Henry Masur, National Institutes of Health, USA Opportunistic Infections in the Era of HAART
Monday, March 31 \| 5:00PM - 7:00PM HIV Pathogenesis II This session is from HIV Research Room: Van Horne Ballroom C Speaker 4 of 6 Patrick S. Moore, University of Pittsburgh Cancer Institute, USA KSHV and Its Designer Genes
Monday, March 31 \| 5:00PM - 7:00PM HIV Pathogenesis II This session is from HIV Research Room: Van Horne Ballroom C Speaker 5 of 6 Joel M. Palefsky, University of California, San Francisco, USA Cofactors: HPV infection
Monday, March 31 \| 5:00PM - 7:00PM HIV Pathogenesis II This session is from HIV Research Room: Van Horne Ballroom C Speaker 6 of 6 W. Henry Boom, Case Western Reserve University, USA M. tuberculosis: Hiding from the Host Implications for HIV-TB
Monday, March 31 \| 7:30PM - 8:30PM Social Hour Room: Alberta/NB/Riverview/Cascade/Conservatory
Monday, March 31 \| 8:00PM - 10:00PM Poster Session 2: The Virus, Antigen Presenting Cells, Innat e and CD4+ T Cell Responses Room: Alberta/NB/Riverview/Cascade/Conservatory
Tuesday, April 01 \| 6:30AM - 8:00AM Breakfast Room: New Brunswick/Riverview/Cascade/Conservatory
Tuesday, April 01 \| 8:00AM - 11:00AM Pioneer Lecture - Immunology (Joint) Room: Van Horne Ballroom Speaker 1 of 2 * † Jack H. Nunberg, University of Montana, USA
Tuesday, April 01 \| 8:00AM - 11:00AM Pioneer Lecture - Immunology (Joint) Room: Van Horne Ballroom Speaker 2 of 2 Susan Zolla-Pazner, Icahn School of Medicine at Mount Sinai, USA Two Decades of Debate: The Role of Antibodies in HIV Immunity
Tuesday, April 01 \| 8:00AM - 11:00AM Immune Responses in HIV Infection (Joint) Room: Van Horne Ballroom Speaker 1 of 4 * David C. Montefiori, Duke University Medical Center, USA Understanding the New Generation of Neutralizing Antibody Assays
Tuesday, April 01 \| 8:00AM - 11:00AM Immune Responses in HIV Infection (Joint) Room: Van Horne Ballroom Speaker 2 of 4 John R. Mascola, NIAID, National Institutes of Health, USA Neutralizing Antibodies and Protective Immunity
Tuesday, April 01 \| 8:00AM - 11:00AM Immune Responses in HIV Infection (Joint) Room: Van Horne Ballroom Speaker 3 of 4 Douglas F. Nixon, Weill Cornell Medicine, USA CD8 T cell Effector Subsets and HIV infection
Tuesday, April 01 \| 8:00AM - 11:00AM Immune Responses in HIV Infection (Joint) Room: Van Horne Ballroom Speaker 4 of 4 Mary Carrington, NCI, National Institutes of Health, USA The Multifaceted Effects of the HLA class I Loci on HIV-1 Disease
Tuesday, April 01 \| 9:20AM - 9:40AM Coffee Break Room: Van Horne Foyer
Tuesday, April 01 \| 11:00AM - 1:00PM Poster Setup Room: Alberta/NB/Riverview/Cascade/Conservatory
Tuesday, April 01 \| 1:00PM - 10:00PM Poster Viewing Room: Alberta/NB/Riverview/Cascade/Conservatory
Tuesday, April 01 \| 4:30PM - 5:00PM Coffee & Snacks Available Room: Van Horne Foyer
Tuesday, April 01 \| 5:00PM - 7:00PM The Envelope and Entry Room: Van Horne Ballroom A-B Speaker 1 of 4 * Dan R. Littman, HHMI/New York University School of Medicine, USA Role of Dendritic Cells in HIV Entry and Host Immune Responses
Tuesday, April 01 \| 5:00PM - 7:00PM The Envelope and Entry Room: Van Horne Ballroom A-B Speaker 2 of 4 Dennis R. Burton, The Scripps Research Institute, USA The Recognition of HIV-1 by Broadly Neutralizing Antibodies: Clues for Vaccine Design
Tuesday, April 01 \| 5:00PM - 7:00PM The Envelope and Entry Room: Van Horne Ballroom A-B Speaker 3 of 4 Peter D. Kwong, NIAID, National Institutes of Health, USA Application of Structural Biology to the Development of an HIV Vaccine
Tuesday, April 01 \| 5:00PM - 7:00PM The Envelope and Entry Room: Van Horne Ballroom A-B Speaker 4 of 4 Cynthia A. Derdeyn, Emory University, USA Short Talk: Selective Heterosexual Transmission of Envelope-constrained, Neutralization-sensitive HIV-1
Tuesday, April 01 \| 5:00PM - 7:00PM Immune Responses (Innate) in HIV Infection II This session is from HIV Research Room: Van Horne Ballroom C Speaker 1 of 6 * Mario Clerici, Dipartimento di Fisiologia Medico-Chirurgica e dei Trapianti, Italy
Tuesday, April 01 \| 5:00PM - 7:00PM Immune Responses (Innate) in HIV Infection II This session is from HIV Research Room: Van Horne Ballroom C Speaker 2 of 6 * Carl W. Dieffenbach, NIAID, National Institutes of Health, USA
Tuesday, April 01 \| 5:00PM - 7:00PM Immune Responses (Innate) in HIV Infection II This session is from HIV Research Room: Van Horne Ballroom C Speaker 3 of 6 Bruce A. Beutler, University of Texas Southwestern Medical Center, USA Forward Genetic Analysis of Innate Immunity
Tuesday, April 01 \| 5:00PM - 7:00PM Immune Responses (Innate) in HIV Infection II This session is from HIV Research Room: Van Horne Ballroom C Speaker 4 of 6 Christine A. Biron, Brown University, USA Interferon and NK Cell Responses to Viral Infections
Tuesday, April 01 \| 5:00PM - 7:00PM Immune Responses (Innate) in HIV Infection II This session is from HIV Research Room: Van Horne Ballroom C Speaker 5 of 6 Jay A. Levy, University of California, San Francisco, USA Innate Immunity: Plasmacytoid Dendritic Cells and the CD8+ Cell Noncytotoxic Anti-HIV Response
Tuesday, April 01 \| 5:00PM - 7:00PM Immune Responses (Innate) in HIV Infection II This session is from HIV Research Room: Van Horne Ballroom C Speaker 6 of 6 Deborah J. Anderson, Brigham and Women's Hospital, USA Genital Tract Mucosal Immunity and HIV Infection
Tuesday, April 01 \| 7:30PM - 8:30PM Social Hour Room: Alberta/NB/Riverview/Cascade/Conservatory
Tuesday, April 01 \| 8:00PM - 10:00PM Poster Session 3: Pre-Clinical/Clinical Evaluation of Vaccin e Strategies Room: Alberta/NB/Riverview/Cascade/Conservatory
Wednesday, April 02 \| 6:30AM - 8:00AM Breakfast Room: New Brunswick/Riverview/Cascade/Conservatory
Wednesday, April 02 \| 8:00AM - 11:00AM Pioneer Lecture - Clinical Approaches This session is from HIV Research Room: Van Horne Ballroom C Speaker 1 of 3 * Salvatore T. Butera, Centers for Disease Control and Prevention, USA
Wednesday, April 02 \| 8:00AM - 11:00AM Pioneer Lecture - Clinical Approaches This session is from HIV Research Room: Van Horne Ballroom C Speaker 2 of 3 * Barbara Weiser, New York State Department of Health, USA
Wednesday, April 02 \| 8:00AM - 11:00AM Pioneer Lecture - Clinical Approaches This session is from HIV Research Room: Van Horne Ballroom C Speaker 3 of 3 Paul A. Volberding, University of California, San Francisco, USA Clinical Care
Wednesday, April 02 \| 8:00AM - 11:00AM Immunopathogenesis I Room: Van Horne Ballroom A-B Speaker 1 of 5 * Rafi Ahmed, Emory University School of Medicine, USA Understanding Immunological Memory to Improve Vaccination Strategies'
Wednesday, April 02 \| 8:00AM - 11:00AM Immunopathogenesis I Room: Van Horne Ballroom A-B Speaker 2 of 5 Bruce D. Walker, Ragon Institute of MGH, MIT and Harvard, USA Immune Control and Immune Failure in HIV Infection
Wednesday, April 02 \| 8:00AM - 11:00AM Immunopathogenesis I Room: Van Horne Ballroom A-B Speaker 3 of 5 Giuseppe Pantaleo, Centre Hospitalier Universitaire Vaudois, Switzerland Protective CD4 and CD8 T Cell Responses in HIV-1 Infection
Wednesday, April 02 \| 8:00AM - 11:00AM Immunopathogenesis I Room: Van Horne Ballroom A-B Speaker 4 of 5 Genoveffa Franchini, NCI, National Institutes of Health, USA Modeling Immune Intervention Strategies for HIV-1 Infection of Humans in the Macaque Model
Wednesday, April 02 \| 8:00AM - 11:00AM Immunopathogenesis I Room: Van Horne Ballroom A-B Speaker 5 of 5 Olivier Schwartz, Institut Pasteur, France HIV and Dendritic Cells: Virus Spread and Antigen Presentation
Wednesday, April 02 \| 8:00AM - 11:00AM Antiviral Strategies I This session is from HIV Research Room: Van Horne Ballroom C Speaker 1 of 4 Carl Grunfeld, Veterans Affairs Medical Center, USA The Role of Antiretroviral Drugs in Metabolic and Fat Distribution Changes of HIV Infection
Wednesday, April 02 \| 8:00AM - 11:00AM Antiviral Strategies I This session is from HIV Research Room: Van Horne Ballroom C Speaker 2 of 4 Edward A. Berger, NIAID, National Institutes of Health, USA Immunotoxins to Target HIV Infected Cell Reservoirs
Wednesday, April 02 \| 8:00AM - 11:00AM Antiviral Strategies I This session is from HIV Research Room: Van Horne Ballroom C Speaker 3 of 4 Flossie Wong-Staal, ItherX Pharmaceuticals Inc., USA Identification of Essential HIV Cellular Co-Factors through Genomic Approaches
Wednesday, April 02 \| 8:00AM - 11:00AM Antiviral Strategies I This session is from HIV Research Room: Van Horne Ballroom C Speaker 4 of 4 Michael M. Lederman, Case Western Reserve University, USA Interleukin-2: A Determinant of Immune Competence in HIV disease? Will Administration Confer Clinical Benefit?
Wednesday, April 02 \| 9:20AM - 9:40AM Coffee Break Room: Van Horne Foyer
Wednesday, April 02 \| 11:00AM - 1:00PM Poster Setup Room: Alberta/NB/Riverview/Cascade/Conservatory
Wednesday, April 02 \| 1:00PM - 10:00PM Poster Viewing Room: Alberta/NB/Riverview/Cascade/Conservatory
Wednesday, April 02 \| 2:30PM - 4:30PM Workshop: Recent Developments in Cytokine Augmentation of Va ccine-Induced Immunity Room: Van Horne Ballroom A-B Speaker 1 of 5 * Robert A. Seder, NIAID, National Institutes of Health, USA
Wednesday, April 02 \| 2:30PM - 4:30PM Workshop: Recent Developments in Cytokine Augmentation of Va ccine-Induced Immunity Room: Van Horne Ballroom A-B Speaker 2 of 5 Karl J. Ljungberg, Karolinska Institutet, Sweden Priming with DNA and Recombinant GM-CSF Followed by Protein CpG-ODN Boost Induces Strong Anti HIV-1 Envelope Immune Responses in Mice
Wednesday, April 02 \| 2:30PM - 4:30PM Workshop: Recent Developments in Cytokine Augmentation of Va ccine-Induced Immunity Room: Van Horne Ballroom A-B Speaker 3 of 5 Dan H. Barouch, Beth Israel Deaconess Medical Center, USA Chemoattractant Plasmid Cytokines Augment DNA Vaccine-Elicited Immune Responses
Wednesday, April 02 \| 2:30PM - 4:30PM Workshop: Recent Developments in Cytokine Augmentation of Va ccine-Induced Immunity Room: Van Horne Ballroom A-B Speaker 4 of 5 * John H. Eldridge, Auro Vaccines, USA Immunogenicity and Protective Capacity of a Cytokine-Enhanced DNA Prime/rVSV Boost Vaccination Regimen in Rhesus Macaques
Wednesday, April 02 \| 2:30PM - 4:30PM Workshop: Recent Developments in Cytokine Augmentation of Va ccine-Induced Immunity Room: Van Horne Ballroom A-B Speaker 5 of 5 David B. Weiner, Wistar Institute, USA Th1 Plasmid Cytokine Enhancement of RNA Optimized Plasmid DNA Vaccine Potency In Non Human Primates Suggests Attainment of a Critical Milestone In DNA Vaccine and Immune Therapy Development
Wednesday, April 02 \| 4:30PM - 5:00PM Coffee & Snacks Available Room: Van Horne Foyer
Wednesday, April 02 \| 5:00PM - 7:00PM Immunopathogenesis II Room: Van Horne Ballroom A-B Speaker 1 of 4 Robert F. Siliciano, Johns Hopkins University School of Medicine, USA Halting HIV Evolution
Wednesday, April 02 \| 5:00PM - 7:00PM Immunopathogenesis II Room: Van Horne Ballroom A-B Speaker 2 of 4 * Douglas D. Richman, University of California, San Diego, USA The Evolution and Neutralization Escape of HIV
Wednesday, April 02 \| 5:00PM - 7:00PM Immunopathogenesis II Room: Van Horne Ballroom A-B Speaker 3 of 4 Daniel C. Douek, NIAID, National Institutes of Health, USA In Vivo distribution of HIV among T cell subsets
Wednesday, April 02 \| 5:00PM - 7:00PM Immunopathogenesis II Room: Van Horne Ballroom A-B Speaker 4 of 4 Louis J. Picker, Oregon Health & Science University, USA T Cell Dynamics in SIV Infection
Wednesday, April 02 \| 5:00PM - 7:00PM HIV Pathogenesis III This session is from HIV Research Room: Van Horne Ballroom C Speaker 1 of 5 * Ronald G. Collman, University of Pennsylvania, USA
Wednesday, April 02 \| 5:00PM - 7:00PM HIV Pathogenesis III This session is from HIV Research Room: Van Horne Ballroom C Speaker 2 of 5 * Loyda M. Meléndez, University of Puerto Rico School of Medicine, USA
Wednesday, April 02 \| 5:00PM - 7:00PM HIV Pathogenesis III This session is from HIV Research Room: Van Horne Ballroom C Speaker 3 of 5 Crystal L. Mackall, Stanford University, USA Therapeutic Modulation of T Cell Homeostasis
Wednesday, April 02 \| 5:00PM - 7:00PM HIV Pathogenesis III This session is from HIV Research Room: Van Horne Ballroom C Speaker 4 of 5 Maria Prins, Municipal Health Service, Netherlands Gender Differences in HIV Infection
Wednesday, April 02 \| 5:00PM - 7:00PM HIV Pathogenesis III This session is from HIV Research Room: Van Horne Ballroom C Speaker 5 of 5 Keith R. Fowke, University of Manitoba, Canada Natural Immunity to HIV Infection
Wednesday, April 02 \| 7:30PM - 8:30PM Social Hour Room: Alberta/NB/Riverview/Cascade/Conservatory
Wednesday, April 02 \| 8:00PM - 10:00PM Poster Session 4: HIV Tropism, Entry and Neutralizing Antibo dies Room: Alberta/NB/Riverview/Cascade/Conservatory
Thursday, April 03 \| 6:30AM - 8:00AM Breakfast Room: NewBrunswick/Riverview/Cascade/Conservatory
Thursday, April 03 \| 8:00AM - 11:00AM Novel Approaches in Pre-Clinical and Clinical Development Room: Van Horne Ballroom A-B Speaker 1 of 4 Robert E. Johnston, Global Vaccines, Inc., USA Use of VEE to Stimulate Protective Immunity to HIV
Thursday, April 03 \| 8:00AM - 11:00AM Novel Approaches in Pre-Clinical and Clinical Development Room: Van Horne Ballroom A-B Speaker 2 of 4 * Philip R. Johnson, Children's Hospital of Philadelphia, USA Pre-clinical Evaluation of a Novel HIV Vaccine Based on an Adeno-associated Virus Vector.
Thursday, April 03 \| 8:00AM - 11:00AM Novel Approaches in Pre-Clinical and Clinical Development Room: Van Horne Ballroom A-B Speaker 3 of 4 Jeffrey D. Lifson, Leidos Biomedical Research, Inc., USA Control of Pathogenic SIV Infection: Different Routes to the Same Goal
Thursday, April 03 \| 8:00AM - 11:00AM Novel Approaches in Pre-Clinical and Clinical Development Room: Van Horne Ballroom A-B Speaker 4 of 4 Brigitte Autran, Hôpital Pitié-Salpétrière, UPMC, France Effect of Therapeutic Vaccination and STI on Immune Control of HIV
Thursday, April 03 \| 8:00AM - 11:00AM HIV Pathogenesis IV This session is from HIV Research Room: Van Horne Ballroom C Speaker 1 of 6 * Peter Simmonds, University of Edinburgh, UK
Thursday, April 03 \| 8:00AM - 11:00AM HIV Pathogenesis IV This session is from HIV Research Room: Van Horne Ballroom C Speaker 2 of 6 Klaus Strebel, NIAID, National Institutes of Health, USA HIV-1 Vif: A Multifunctional Adaptor Molecule
Thursday, April 03 \| 8:00AM - 11:00AM HIV Pathogenesis IV This session is from HIV Research Room: Van Horne Ballroom C Speaker 3 of 6 Frederic D. Bushman, University of Pennsylvania, USA Twenty Years of Research on Retroviral Integration
Thursday, April 03 \| 8:00AM - 11:00AM HIV Pathogenesis IV This session is from HIV Research Room: Van Horne Ballroom C Speaker 4 of 6 Tristram G. Parslow, Emory University, USA RNA Dimers as Templates for Viral and Cellular Reverse Transcription
Thursday, April 03 \| 8:00AM - 11:00AM HIV Pathogenesis IV This session is from HIV Research Room: Van Horne Ballroom C Speaker 5 of 6 * David Camerini, University of California, Irvine, USA
Thursday, April 03 \| 8:00AM - 11:00AM HIV Pathogenesis IV This session is from HIV Research Room: Van Horne Ballroom C Speaker 6 of 6 James J. Goedert, National Institutes of Health, USA Roles of Hepatitis C virus (HCV) and GB virus C (GBV-C) in HIV Pathogenesis
Thursday, April 03 \| 9:20AM - 9:40AM Coffee Break Room: Van Horne Foyer
Thursday, April 03 \| 4:30PM - 5:00PM Coffee & Snacks Available Room: Van Horne Foyer
Thursday, April 03 \| 5:00PM - 7:00PM Late Breakers Room: Van Horne Ballroom A-B Speaker 1 of 9 * Richard A. Koup, NIAID, National Institutes of Health, USA
Thursday, April 03 \| 5:00PM - 7:00PM Late Breakers Room: Van Horne Ballroom A-B Speaker 2 of 9 Daniel E. Kaufmann, University of Montreal, Canada Short Talk: Comprehensive Analysis of HIV-Specific CD4 Responses by IFN-Gamma Elispot in Early Chronic HIV-1 Infection Shows Marked Immunodominance of gag and nef and the Presence of Broadly Recognized Peptides
Thursday, April 03 \| 5:00PM - 7:00PM Late Breakers Room: Van Horne Ballroom A-B Speaker 3 of 9 Victor Appay, INSERM U1135 - CIMI, France Short Talk: Activation and Differentiation of HIV Non-Specific CD8+ T Cells During HIV-1 Infection
Thursday, April 03 \| 5:00PM - 7:00PM Late Breakers Room: Van Horne Ballroom A-B Speaker 4 of 9 Matthew R. Reynolds, University of Wisconsin-Madison, USA Short Talk: Viral Dissemination and Kinetics of Cytotoxic T-Lymphocyte Development in Mamu-A01 Positive Macaques Infected with SIVmac239*
Thursday, April 03 \| 5:00PM - 7:00PM Late Breakers Room: Van Horne Ballroom A-B Speaker 5 of 9 Ann Chahroudi, Emory University School of Medicine, USA Short Talk: Towards Better Strategies for Poxvirus-Based HIV Vaccines: Studies of the Cellular Tropism of Modified Vaccinia Ankara (MVA) and Vaccinia Virus (VV) in Primary Human Cells
Thursday, April 03 \| 5:00PM - 7:00PM Late Breakers Room: Van Horne Ballroom A-B Speaker 6 of 9 Teunis B.H. Geijtenbeek, University of Amsterdam, Netherlands Short Talk: Mycobacteria Suppress Dendritic Cell Function: Effects on HIV-1 Infection
Thursday, April 03 \| 5:00PM - 7:00PM Late Breakers Room: Van Horne Ballroom A-B Speaker 7 of 9 John P. Moore, Weill Medical College of Cornell University, USA Short Talk: Prevention of Virus Transmission to Macaque Monkeys by Vaginally Applied Entry Inhibitors
Thursday, April 03 \| 5:00PM - 7:00PM Late Breakers Room: Van Horne Ballroom A-B Speaker 8 of 9 Leonidas Stamatatos, Fred Hutchinson Cancer Research Center, USA Short Talk: Priming by Vaccination of HIV Envelope-Specific B-Cell Responses Allows for the Long-Term Control of SHIVSF162P4-Replication in Macaques
Thursday, April 03 \| 5:00PM - 7:00PM Late Breakers Room: Van Horne Ballroom A-B Speaker 9 of 9 Pascal Poignard, IAVI Neutralizing Antibody Center at The Scripps Research Institute, USA Short Talk: Stoichiometry of Neutralization of the Primary HIV-1 Isolate JR-CSF by the Anti-CD4 Binding Site Antibody b12
Thursday, April 03 \| 5:00PM - 7:00PM Late Breaking Observations and Conclusions This session is from HIV Research Room: Van Horne Ballroom C Speaker 1 of 9 * Alan L. Landay, Rush Medical University, USA
Thursday, April 03 \| 5:00PM - 7:00PM Late Breaking Observations and Conclusions This session is from HIV Research Room: Van Horne Ballroom C Speaker 2 of 9 Jerome A. Zack, University of California, Los Angeles, USA Strategies to Eliminate Latent HIV
Thursday, April 03 \| 5:00PM - 7:00PM Late Breaking Observations and Conclusions This session is from HIV Research Room: Van Horne Ballroom C Speaker 3 of 9 David M. Margolis, University of North Carolina at Chapel Hill, USA Derepression by DNA-binding Polyamides Allows Outgrowth of Human Immunodeficiency Type 1 from Resting CD4+ T Cells: Regulators of HIV Latency
Thursday, April 03 \| 5:00PM - 7:00PM Late Breaking Observations and Conclusions This session is from HIV Research Room: Van Horne Ballroom C Speaker 4 of 9 Thomas J. Hope, Northwestern University, USA Enhancement of HIV Infection by Dendritic Cells: Transfer of HIV to Target Cells Through an Infectious Synapse
Thursday, April 03 \| 5:00PM - 7:00PM Late Breaking Observations and Conclusions This session is from HIV Research Room: Van Horne Ballroom C Speaker 5 of 9 Leonid Margolis, NICHD, National Institutes of Health, USA Viral Interactions in HIV-Infected Human Lymphoid Tissue
Thursday, April 03 \| 5:00PM - 7:00PM Late Breaking Observations and Conclusions This session is from HIV Research Room: Van Horne Ballroom C Speaker 6 of 9 Joshua J. Anzinger, NHLBI, National Institutes of Health, USA Attachment Levels of HIV Differ between PBMC Donors In A CD4 Independent Manner
Thursday, April 03 \| 5:00PM - 7:00PM Late Breaking Observations and Conclusions This session is from HIV Research Room: Van Horne Ballroom C Speaker 7 of 9 Edward Barker, Rush University Medical Center, USA Inability of Natural Killer Cells to Destroy Autologous HIV-Infected Primary CD4+ T Cells
Thursday, April 03 \| 5:00PM - 7:00PM Late Breaking Observations and Conclusions This session is from HIV Research Room: Van Horne Ballroom C Speaker 8 of 9 David J. Volsky, Columbia University, St. Luke's Roosevelt Hospital Center, USA Interaction of HIV with Astrocytes: A Case for a Direct Role of HIV in Neuropathogenesis
Thursday, April 03 \| 5:00PM - 7:00PM Late Breaking Observations and Conclusions This session is from HIV Research Room: Van Horne Ballroom C Speaker 9 of 9 Lishan Su, University of North Carolina at Chapel Hill, USA A Novel Genetic Approach to Inactivating Chemokine Receptors by a Modified HIV Protein
Thursday, April 03 \| 7:30PM - 8:30PM Social Hour Room: Alberta/NB/Riverview/Cascade/Conservatory
Thursday, April 03 \| 8:30PM - 11:30PM Entertainment Room: Alberta/NB/Riverview/Cascade/Conservatory
Thursday, April 03 \| 8:30PM - 11:30PM Cash Bar Room: Alberta/NB/Riverview/Cascade/Conservatory
Friday, April 04 \| 10:26AM - 10:26AM Departure *Session Chair.